[ascct] FDA/Critical Path Institute Modeling Workshop

  • From: Kristie Sullivan <KSullivan@xxxxxxxx>
  • To: "ascct@xxxxxxxxxxxxx" <ascct@xxxxxxxxxxxxx>
  • Date: Wed, 21 Aug 2013 15:45:14 -0400

Drug development and regulatory review have become increasingly challenging and 
resource intensive. An integrated strategic approach to developing and applying 
modeling and simulation tools in drug development will enhance decision-making 
processes. This workshop will examine:

*        Novel tools and approaches to accelerate the development of 
efficacious medicines with optimal benefit/risk profiles
*        Successes and lessons learned in the use of modeling and simulation by 
FDA, industry, and public-private-partnerships
*        Challenges and opportunities for these innovative approaches


Attachment: image001.png
Description: image001.png

Attachment: image002.png
Description: image002.png

Attachment: image003.png
Description: image003.png

Attachment: MS_Sept 26_Workshop_Agenda_2013 08 09.pdf
Description: MS_Sept 26_Workshop_Agenda_2013 08 09.pdf

Attachment: M&S WORKSHOP_Sept 24 2013_SPONSORSHIP OPPORTUNITIES.pdf
Description: M&S WORKSHOP_Sept 24 2013_SPONSORSHIP OPPORTUNITIES.pdf

Other related posts:

  • » [ascct] FDA/Critical Path Institute Modeling Workshop - Kristie Sullivan